| Product Code: ETC7623063 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland experienced a notable shift in its allopurinol import sources, with Switzerland, Belgium, USA, UK, and China emerging as top exporters. This diversification is reflected in the decrease in market concentration from 2023. Despite a decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period 2020-24 remained strong at 11.32%. This data suggests a dynamic market landscape for allopurinol imports in Ireland, signaling opportunities for market players to adapt to changing supplier dynamics and potential avenues for strategic partnerships.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Allopurinol Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Allopurinol Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Allopurinol Market - Industry Life Cycle |
3.4 Ireland Allopurinol Market - Porter's Five Forces |
3.5 Ireland Allopurinol Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Allopurinol Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Allopurinol Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Ireland Allopurinol Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Ireland Allopurinol Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Allopurinol Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gout and other related conditions in Ireland |
4.2.2 Growing awareness about the benefits of allopurinol in managing gout |
4.2.3 Rising healthcare expenditure and focus on chronic disease management |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products |
4.3.2 Competition from alternative medications and treatments |
4.3.3 Potential side effects and safety concerns associated with allopurinol |
5 Ireland Allopurinol Market Trends |
6 Ireland Allopurinol Market, By Types |
6.1 Ireland Allopurinol Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Allopurinol Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ireland Allopurinol Market Revenues & Volume, By Antigout Agents, 2021- 2031F |
6.1.4 Ireland Allopurinol Market Revenues & Volume, By Antihyperuricemic Agents, 2021- 2031F |
6.2 Ireland Allopurinol Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Allopurinol Market Revenues & Volume, By Gout, 2021- 2031F |
6.2.3 Ireland Allopurinol Market Revenues & Volume, By Kidney Stones, 2021- 2031F |
6.2.4 Ireland Allopurinol Market Revenues & Volume, By Others, 2021- 2031F |
6.2.5 Ireland Allopurinol Market Revenues & Volume, By Demographic, 2021- 2031F |
6.2.6 Ireland Allopurinol Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.7 Ireland Allopurinol Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3 Ireland Allopurinol Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Ireland Allopurinol Market Revenues & Volume, By Intravenous Powder for Injection, 2021- 2031F |
6.3.3 Ireland Allopurinol Market Revenues & Volume, By Oral Tablet, 2021- 2031F |
6.4 Ireland Allopurinol Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Ireland Allopurinol Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 Ireland Allopurinol Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.4 Ireland Allopurinol Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Allopurinol Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Allopurinol Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Ireland Allopurinol Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Ireland Allopurinol Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Ireland Allopurinol Market Import-Export Trade Statistics |
7.1 Ireland Allopurinol Market Export to Major Countries |
7.2 Ireland Allopurinol Market Imports from Major Countries |
8 Ireland Allopurinol Market Key Performance Indicators |
8.1 Number of prescriptions for allopurinol filled in Ireland |
8.2 Patient adherence rates to allopurinol therapy |
8.3 Number of healthcare providers offering allopurinol as a treatment option |
8.4 Rate of gout cases diagnosed and treated with allopurinol |
8.5 Patient satisfaction and reported outcomes with allopurinol therapy |
9 Ireland Allopurinol Market - Opportunity Assessment |
9.1 Ireland Allopurinol Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Allopurinol Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Allopurinol Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Ireland Allopurinol Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Ireland Allopurinol Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Allopurinol Market - Competitive Landscape |
10.1 Ireland Allopurinol Market Revenue Share, By Companies, 2024 |
10.2 Ireland Allopurinol Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here